SII to apply for Oxford COVID-19 vaccine trials in India in a week
New Delhi: The Serum Institute of India (SII) will soon apply to the Indian regulator for the licensure trials of the AstraZeneca-Oxford COVID-19 vaccine.
Commenting on the AstraZeneca-Oxford vaccine's results, Adar Poonawalla, CEO,…